CT26.WT Cells

CT26.WT is a clonally derived cell line from the parent CT26 cell line, which itself was established from a colon carcinoma induced in a BALB/c mouse using the carcinogen N-nitroso-N-methylurethane (NNMU). This cloning process was performed to obtain a cell line with consistent characteristics and reproducible results in experimental setups. As a result, CT26.WT retains the undifferentiated carcinoma phenotype of its progenitor, making it a robust model for studying various aspects of colorectal cancer, including tumor genesis, progression, and the tumor microenvironment.
This cell line is extensively used in oncological research, particularly in the study of immune responses to tumors. Its compatibility with BALB/c mice, which are genetically identical to the source of the CT26.WT cells, allows researchers to study the complex interactions between cancer cells and the immune system in a controlled yet biologically relevant setting. The use of CT26.WT in syngeneic murine models helps in the investigation of immunotherapeutic strategies, such as the efficacy of novel immunomodulatory agents and the role of immune checkpoints in cancer progression. This facilitates the development of more effective cancer treatments that can later be adapted for human clinical trials.